Wanchao M. Yin
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Author Correction: Structural insights into antagonist recognition by the vasopressin V2 receptor.
Journal: Nature communications
Published: March 24, 2026
Correction to "Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate".
Journal: Journal of medicinal chemistry
Published: December 12, 2025
Molecular architecture of OXGR1 reveals an evolutionary conserved mechanisms for metabolite surveillance.
Journal: The EMBO journal
Published: September 28, 2025
Discovery and mutasynthetic optimization of ansatrienin B: A new broad-spectrum inhibitor against RNA viruses.
Journal: Acta pharmaceutica Sinica. B
Published: July 21, 2025
Structural basis of the cysteinyl leukotriene receptor type 2 activation by LTD4.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 07, 2025
Divergent activation patterns of BRS3 revealed by two Chinese herb-derived agonists.
Journal: Acta pharmaceutica Sinica. B
Published: February 25, 2025
Harnessing the Magic Methyl Effect: Discovery of CLPP-2068 as a Novel HsClpP Activator for the Treatment of Diffuse Large B-Cell Lymphoma.
Journal: Journal of medicinal chemistry
Published: February 12, 2025
Structural insights into the activation of TMEM175 by small molecule.
Journal: Neuron
Published: January 06, 2025
Structural insights into antagonist recognition by the vasopressin V2 receptor.
Journal: Nature communications
Published: October 09, 2024
The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations.
Journal: mBio
Published: March 26, 2024
Last Updated: 09/26/2026